Imodiumliquicaps

Loperamide Hydrochloride, the active ingredient in Imodiumliquicaps, is a peripherally acting opioid receptor agonist presented as a capsule for oral use. It treats acute and chronic diarrhea, including diarrhea associated with irritable bowel syndrome, in adults and children as appropriate.

GNH USA supplies Imodiumliquicaps as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Loperamide Hydrochloride works on the gastrointestinal tract to reduce excessive bowel movements and fluid loss. It is indicated for: - Acute diarrhea: provides symptomatic relief by slowing intestinal transit. - Chronic diarrhea: helps maintain stool consistency in long‑term diarrheal conditions. - Irritable bowel syndrome with diarrhea (IBS‑D): reduces urgency and frequency of stools.

Loperamide Hydrochloride is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Constipation: reduced bowel movements may become overly slow. - Abdominal cramps: mild to moderate discomfort. - Nausea: occasional feeling of queasiness. - Dizziness: transient light‑headedness. - Dry mouth: reduced salivation. - Flatulence: increased gas production.

Serious or Rare Side Effects: - Severe constipation leading to bowel obstruction. - Toxic megacolon in patients with ulcerative colitis. - Cardiac arrhythmias at high plasma concentrations. - Allergic reactions such as rash, itching, or swelling. - Central nervous system depression in overdose. - Liver enzyme elevation in rare cases.

Before using Imodiumliquicaps, consider the following safety measures: - Contraindicated in patients with known hypersensitivity to loperamide. - Avoid in children younger than 2 years without medical supervision. - Use with caution in patients with hepatic impairment. - Do not exceed recommended dosing; prolonged use may mask underlying infection. - Monitor for signs of severe constipation or abdominal distension. - Store at ambient temperature below 25°C: keep in the original container, protect from moisture and direct sunlight.

Loperamide Hydrochloride may interact with other medicines, altering its effectiveness or safety.

Major Interactions (Avoid): - CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): can increase loperamide plasma levels. - P‑glycoprotein inhibitors (e.g., quinidine, ritonavir): may raise systemic exposure.

Moderate Interactions (Monitor Closely): - Other antidiarrheal agents: additive effect on gut motility. - Opioid analgesics: potential for enhanced central opioid effects. - Anticholinergic drugs: may increase risk of constipation. - Antifungal azoles (e.g., itraconazole): moderate increase in loperamide concentrations.